Table 5.
Multivariate Analysis of Clinical Factors Related to Eradication Failure in Each Group
| Clinical factor | Coefficient | SE | OR (95% CI) | p-value |
|---|---|---|---|---|
| Standard triple therapy plus probiotics | ||||
| Age | 0.04 | 0.02 | 1.04 (1.01–1.07) | 0.011 |
| Type of probiotic (STP-I vs STP-II) | 0.92 | 0.39 | 2.50 (1.17–5.37) | 0.019 |
| Concomitant therapy | ||||
| Type 2 DM | 5.02 | 1.62 | 152.12 (6.34–3,648.4) | 0.002 |
| Alcohol | 3.56 | 1.40 | 35.08 (2.27–541.97) | 0.011 |
SE, standard error; OR, odds ratio; CI, confidence interval; STP, standard triple therapy plus probiotics; STP-I, Bacillus subtilis and Streptococcus faecium culture; STP-II, Lactobacillus casei var. rhamnosus culture; DM, diabetes mellitus.